13.07.2015 Views

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

With these doses, the rate <strong>of</strong> necrosis is less than 1%. Tolerancedoses <strong>of</strong> the upper vagina and surface <strong>of</strong> the distal vagina are140 Gy and 100Gy, respectively. Threshold doses reported<strong>for</strong> vesico-vaginal fistula is 150Gy and <strong>for</strong> recto-vaginal fistulais 80 Gy (4). Hence a combination <strong>of</strong> external andbrachytherapy is <strong>of</strong>fered to cervical cancers. The radiationinduced side effects and their manifestations depend on thetype <strong>of</strong> tissues receiving radiation i.e. early or late respondingnormal tissues and the radiation tolerances. Early respondingtissues like, the skin and intestinal mucosa have a high cellturnover rate and they express radiation injury earlier, at about2 to 3 weeks. Conversely, late responding tissues, like spinalcord, rectum, bladder, or kidneys have a slow cell turnover ornon-proliferating, thus expressing radiation injury many yearslater after treatment.Classification <strong>of</strong> Radiation Induced ReactionsBroadly, reactions may be divided into acute, subacute andlate. Acute reactions are those which manifest while ontreatment or within 3 months, subacute reactions arise between3 to 6 months and late reactions become apparent after 6months <strong>of</strong> treatment. Adverse event (AE) reporting in oncologyhas evolved from unceremonious metaphors to a highlysystematized method. The Common Terminology Criteria <strong>for</strong>Adverse Events (CTCAE) is the principal system <strong>for</strong>describing the severity <strong>of</strong> AE’s commonly encountered inoncology clinical studies. CTCAE clinical descriptors havebeen developed empirically during more than 30 years <strong>of</strong> use.The method <strong>of</strong> data collection is clinician based. Limitations<strong>of</strong> the CTC system include potential <strong>for</strong> incomplete reportingand limited guidance on data analysis and presentationmethods.Early reactions manifest clinically during the course <strong>of</strong>radiotherapy, and are generally due to mitotic-linked cell deathin rapidly dividing tissues and secondary impaired tissue265

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!